IP Verse

Methods For Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan And Oxaliplatin - EP3337478

PATENT ANALYSIS

Patent Details

Grant Date
Aug 12, 2020
Company
IPSEN BIOPHARM LTD.
Oppositions

GENERICS [UK] LIMITED

SANDOZ AG

More patents of Ipsen Biopharm Ltd.

EP3266456

EP3337467

EP3337478

Want to monitor this patent?

Feel free to send us a message here and we will get back to you